ReviewGM crops & food2026
Market introduction of plant varieties and products with gene-edited traits.
Review in GM crops & food, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Molecular Targets and Trait Innovation in CRISPR-Edited Vegetable Crops: An Up-to-Date Review (2020-2026).Plants (Basel, Switzerland) · 2026Review
- Beyond the Edit: Integrating CRISPR-Cas Genome Editing Into the Cereal Breeding Pipeline.International journal of genomics · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gene editing technologies can be used to develop new traits in plants by modifying DNA at specific locations. In many countries, plants made using these techniques, collectively called New Genomic Techniques (NGTs), are being regulated more leniently than transgenic genetically modified organisms (GMOs), opening possibilities for releasing gene-edited plant varieties onto the market. In other countries, including the European Union (EU), proposals for an adapted regulation are in discussion. We describe how the different types of modifications made with NGTs are regulated across the world. We provide an updated overview of gene-edited plant products that have been marketed worldwide, approved, or are currently in field trials. Consumer perception may be a challenge for plant products made using NGTs, but otherwise the commercialization of these new varieties faces the same challenges as new conventional products, including farmer and processor needs, market competition, and consumer preferences.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.